Concepedia

Cornelius Fritsch

CF

8

Publications

673

Citations

8

H-Index

2002

Active since

Affiliations

Novartis (Switzerland)(Current)

Hexal (Germany)

German Cancer Research Center

Novartis (Austria)

Cornelius Fritsch is an author at Novartis (Switzerland) specializing in medicine, molecular biology, and natural sciences.

Top concepts

Publications per year

2002–2018

8

Publications

8

c-FLIPR, a New Regulator of Death Receptor-induced Apoptosis

Alexander Golks, Dirk Brenner, Cornelius Fritsch et al. · Journal of Biological Chemistry · 2005 · 271 citations · Full text

Physicochemical and Functional Comparability Between the Proposed Biosimilar Rituximab GP2013 and Originator Rituximab

Jan Marinus Visser, Isabel Feuerstein, Thomas Stangler et al. · BioDrugs · 2013 · 178 citations · Full text

Negative Feedback Regulation of MKK6 mRNA Stability by p38α Mitogen-Activated Protein Kinase

Concetta Ambrosino, Gaëtane Macé, Stefanie Galbán et al. · Molecular and Cellular Biology · 2002 · 72 citations · Full text

, , +21

Dynamic Fluctuations of Protein-Carbohydrate Interactions Promote Protein Aggregation

Vladimir Voynov, Naresh Chennamsetty, Veysel Kayser et al. · PLoS ONE · 2009 · 42 citations · Full text

, , +13

The structure-function relationship of disulfide bonds in etanercept

William C. Lamanna, Robert Ernst Mayer, Alfred Rupprechter et al. · Scientific Reports · 2017 · 30 citations · Full text

Rows per page

1–5 of 8